AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: DELFAVERO A ROILA F DEANGELIS V TONATO M BALLATORI E TUMOLO S MENEGHETTI L NEGRI D DELLAGASPERA S PRESOT C MURAN G LUCENTI A CICCARESE G PALLADINO MA PORROZZI S SABBATINI R DEPENNI R FEDERICO M SILINGARDI V SANSONI E MALTONI M MILANDRI C AMADORI D SABBIONI R NORTILLI R CETTO GL DOGLIOTTI L BUNIVA T GORZEGNO G LOPEZ M AMODIO A CONTI F FOGGI CM GIGLIO A DESIO L MANENTE P BERNARDO G STRADA MR VILLANI G GALLO L MERLINI L CAROTI C MAZZOTTA S FORCIGNANO R QUARTA G PACILIO C IODICE G ROSATI G MALACARNE P DONATI D MACCAFERRI R COMELLA G CASARETTI R CARRECA I RAUSA L FOSSER V SCHIAVON S GIOFFRE FM VENUTI A AMUNNI G VILLANUCCI A CONTU A PAZZOLA A PALMIOTTI G GAROFOLO G EPIFANI C GIORDANO M ANTIMI M MINELLI M DEVITA F DIGRAZIA M CRUCIANI G MONTANARI L MARCHEI P AMICI S ALESSANDRONI P CECCOLINI M CATTANEO MT ORLANDINI B AGOSTARA B MARZI M DIONISI MS DICOSTANZO F TROCCOLI L
Citation: A. Delfavero et al., TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Annals of oncology, 9(7), 1998, pp. 759-765
P-VEBEC VS MINI-CEOP - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL TO EVALUATE THE EFFICACY, TOLERABILITY AND QUALITY-OF-LIFE OF 2 SCHEDULE SPECIFICALLY DEVISED FOR ELDERLY PATIENTS AFFECTED BY DIFFUSE LARGE-CELL LYMPHOMA (DLCL)
Authors: BERTINI M MERLI F MOZZANA R CABRAS M LIBERATI M VITOLO U BERTE R SILINGARDI V CASSI E MONTALBETTI L RESEGOTTI L
Citation: M. Bertini et al., P-VEBEC VS MINI-CEOP - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL TO EVALUATE THE EFFICACY, TOLERABILITY AND QUALITY-OF-LIFE OF 2 SCHEDULE SPECIFICALLY DEVISED FOR ELDERLY PATIENTS AFFECTED BY DIFFUSE LARGE-CELL LYMPHOMA (DLCL), Annals of oncology, 9, 1998, pp. 60-60
EFFICACY OF 2 DIFFERENT PROMACE-CYTABOM DERIVED REGIMENS IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A MULTICENTER TRIALCONDUCTED BY GISL
Authors: FEDERICO M CLO V BURGIATELLI M CAROTENUTO M GOBBI PG VALLISA D LOMBARDO M AVANZINI P DIRENZO N DINI D BALDINI L SILINGARDI V
Citation: M. Federico et al., EFFICACY OF 2 DIFFERENT PROMACE-CYTABOM DERIVED REGIMENS IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A MULTICENTER TRIALCONDUCTED BY GISL, Haematologica, 83(9), 1998, pp. 800-811
LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE
Authors: GOBBI PG PIERESCA C GHIRARDELLI ML DIRENZO N FEDERICO M MERIL F IANNITTO E PITINI V GRIGNANI G DONELLI A CAROTENUTO M SILINGARDI V
Citation: Pg. Gobbi et al., LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE, Blood, 91(8), 1998, pp. 2704-2712
DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS
Authors: BALLATORI E ROILA F DEANGELIS V RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M TRASSOLDATI A SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A ALLEGRINI G CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E RAMPONI S LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS, Annals of oncology, 8(6), 1997, pp. 561-567
DOUBLE-BLIND, MULTICENTER, RANDOMIZED TRIAL TO COMPARE THE EFFECT OF 2 DOSES OF ADRENOCORTICOTROPIC HORMONE VERSUS PLACEBO IN CONTROLLING DELAYED EMESIS AFTER HIGH-DOSE CISPLATIN IN ADULT PATIENTS WITH CANCER
Authors: PASSALACQUA R COCCONI G CAMINITI C SILINGARDI V BELLA MA BICHISAO E MICHIARA M MALAVASI V DONATI D DICOSTANZO F ROCCA A DISARRA S SCAGLIONE F FRASCHINI F
Citation: R. Passalacqua et al., DOUBLE-BLIND, MULTICENTER, RANDOMIZED TRIAL TO COMPARE THE EFFECT OF 2 DOSES OF ADRENOCORTICOTROPIC HORMONE VERSUS PLACEBO IN CONTROLLING DELAYED EMESIS AFTER HIGH-DOSE CISPLATIN IN ADULT PATIENTS WITH CANCER, Journal of clinical oncology, 15(6), 1997, pp. 2467-2473
HODGKINS-DISEASE PRESENTING BELOW THE DIAPHRAGM - THE EXPERIENCE OF THE GRUPPO-ITALIANO-STUDIO-LINFOMI (GISL)
Authors: IANNITTO E ACCURSO V FEDERICO M VALLISA D PIERESCA C GRAVINA SF DICOSTANZO F DITRAPANI R SILINGARDI V MARIANI G
Citation: E. Iannitto et al., HODGKINS-DISEASE PRESENTING BELOW THE DIAPHRAGM - THE EXPERIENCE OF THE GRUPPO-ITALIANO-STUDIO-LINFOMI (GISL), Haematologica, 82(6), 1997, pp. 676-682
CHANGES OF BIOLOGICAL FEATURES IN BREAST-CANCER CELLS DETERMINED BY PRIMARY CHEMOTHERAPY
Authors: FRASSOLDATI A ADAMI F BANZI C CRISCUOLO M PICCININI L SILINGARDI V
Citation: A. Frassoldati et al., CHANGES OF BIOLOGICAL FEATURES IN BREAST-CANCER CELLS DETERMINED BY PRIMARY CHEMOTHERAPY, Breast cancer research and treatment, 44(3), 1997, pp. 185-192
A PILOT-STUDY ON THE USE OF THE PROMACE CYTABOM REGIMEN AS A FIRST-LINE TREATMENT OF ADVANCED FOLLICULAR NON-HODGKINS-LYMPHOMA
Authors: BALDINI L GUFFANTI A GOBBI P COLOMBI M FEDERICO M AVANZINI P CAVANNA L PIERESCA C SILINGARDI V MAIOLO AT
Citation: L. Baldini et al., A PILOT-STUDY ON THE USE OF THE PROMACE CYTABOM REGIMEN AS A FIRST-LINE TREATMENT OF ADVANCED FOLLICULAR NON-HODGKINS-LYMPHOMA, Cancer, 79(6), 1997, pp. 1234-1240
COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL)
Authors: BRUGIATELLI M FEDERICO M GOBBI P DIRENZO N VALLISA D ANGRILLI F COLOMBI M ASCARI E SILINGARDI V AMADORI S
Citation: M. Brugiatelli et al., COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL), Blood, 90(10), 1997, pp. 840-840
MULTIFOCAL LEUKOENCEPHALOPATHY ASSOCIATED WITH 5-FLUOROURACIL AND LEVAMISOLE ADJUVANT THERAPY FOR COLON-CANCER - A REPORT OF 2 CASES AND REVIEW OF THE LITERATURE
Authors: LUPPI G ZOBOLI A BARBIERI F CRISI G PICCININI L SILINGARDI V
Citation: G. Luppi et al., MULTIFOCAL LEUKOENCEPHALOPATHY ASSOCIATED WITH 5-FLUOROURACIL AND LEVAMISOLE ADJUVANT THERAPY FOR COLON-CANCER - A REPORT OF 2 CASES AND REVIEW OF THE LITERATURE, Annals of oncology, 7(4), 1996, pp. 412-415
VINBLASTINE, BLEOMYCIN, AND METHOTREXATE CHEMOTHERAPY PLUS EXTENDED-FIELD RADIOTHERAPY IN EARLY, FAVORABLY PRESENTING, CLINICALLY STAGED HODGKINS PATIENTS - THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI EXPERIENCE
Authors: GOBBI PG PIERESCA C FRASSOLDATI A CAROTENUTO M DIRENZO N LASALA A BERTE R AVANZINI P FEDERICO M SILINGARDI V ASCARI E
Citation: Pg. Gobbi et al., VINBLASTINE, BLEOMYCIN, AND METHOTREXATE CHEMOTHERAPY PLUS EXTENDED-FIELD RADIOTHERAPY IN EARLY, FAVORABLY PRESENTING, CLINICALLY STAGED HODGKINS PATIENTS - THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI EXPERIENCE, Journal of clinical oncology, 14(2), 1996, pp. 527-533
CCNU, VINBLASTINE, PROCARBAZINE AND PREDNISONE (CVPP) WITH EXTENDED-FIELD RADIOTHERAPY IN THE TREATMENT OF EARLY UNFAVORABLE HODGKINS-DISEASE - A PROSPECTIVE-STUDY ON BEHALF OF THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI (GISL)
Authors: GOBBI PG PIERESCA C CAVANNA L CORBELLA F VALLISA D FEDERICO M FORMISANO R CAROTENUTO M MERLI F CALLEA V ANGRILLI F SILINGARDI V
Citation: Pg. Gobbi et al., CCNU, VINBLASTINE, PROCARBAZINE AND PREDNISONE (CVPP) WITH EXTENDED-FIELD RADIOTHERAPY IN THE TREATMENT OF EARLY UNFAVORABLE HODGKINS-DISEASE - A PROSPECTIVE-STUDY ON BEHALF OF THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI (GISL), Haematologica, 81(6), 1996, pp. 503-512
INTERNATIONAL PROGNOSTIC INDEX (IPI) AND AGE-ADJUSTED IPI (AA-IPI) ARE IMPROVED BY TUMOR BURDEN (TD) EVALUATION
Authors: GRIGNANI G BRUGIATELLI M GOBBI PG PIERESCA C DIRENZO N IANNITTO E MOLICA S SANTAGATI G GINALDI L CARACCIOLO F SILINGARDI V
Citation: G. Grignani et al., INTERNATIONAL PROGNOSTIC INDEX (IPI) AND AGE-ADJUSTED IPI (AA-IPI) ARE IMPROVED BY TUMOR BURDEN (TD) EVALUATION, Blood, 88(10), 1996, pp. 905-905
PROMECE-CYTABOM VS MACOP-B IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - LONG-TERM RESULTS OF A MULTICENTER STUDY OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL)
Authors: SILINGARDI V FEDERICO M CAVANNA L AVANZINI P GOBBI PG LOMBARDO M CAROTENUTO M FRASSOLDATI A PIERESCA C VALLISA D MERLI F ASCARI E MAURI C
Citation: V. Silingardi et al., PROMECE-CYTABOM VS MACOP-B IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - LONG-TERM RESULTS OF A MULTICENTER STUDY OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL), Leukemia & lymphoma, 17(3-4), 1995, pp. 313-320
ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+ KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS/
Authors: LONGO G FEDERICO M PIERESCA C AVANZINI P IANNITTO E DIPRISCO AU BALDINI L BRUGIATELLI M CLO V BEVINI M SILINGARDI V
Citation: G. Longo et al., ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+ KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS/, European journal of cancer, 31A(11), 1995, pp. 1763-1767
A COMPARISON OF THE ANTIEMETIC EFFICACY AND SAFETY OF INTRAMUSCULAR AND INTRAVENOUS FORMULATIONS OF GRANISETRON IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: CONTU A OLMEO N PIRO S SABBATINI R DEPENNI R SILINGARDI V ZANIBONI A MERIGGI F DONATI D MAESTRI A TATEO S CARPI A CAMPORA E CORIA B RIVA E BARBIERI P
Citation: A. Contu et al., A COMPARISON OF THE ANTIEMETIC EFFICACY AND SAFETY OF INTRAMUSCULAR AND INTRAVENOUS FORMULATIONS OF GRANISETRON IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY, Anti-cancer drugs, 6(5), 1995, pp. 652-656
PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: BALLATORI E ROILA F DEANGELIS V TONATO M RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A COLELLA E CIRULLI S SABBATINI R FEDERICO M BARBIERI F SILINGARDI V ANNA S DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI Z MERIGGI F CORTESI E CALABRO F CARLO S LUPORINI G DANTONA A SANTORO A GIACOBONE A MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 13(9), 1995, pp. 2417-2426
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS
Authors: SABBATINI R FEDERICO M BALDINI L BARBIERI F MAIOLO MT SILINGARDI V
Citation: R. Sabbatini et al., A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS, Haematologica, 80(5), 1995, pp. 416-420
EFFECTS OF THYMOSTIMULIN WITH COMBINATION CHEMOTHERAPY IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: FEDERICO M GOBBI PG MORETTI G AVANZINI P DIRENZO N CAVANNA L ASCARI E SILINGARDI V
Citation: M. Federico et al., EFFECTS OF THYMOSTIMULIN WITH COMBINATION CHEMOTHERAPY IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA, American journal of clinical oncology, 18(1), 1995, pp. 8-14
DEXAMETHASONE, GRANISETRON, OR BOTH FOR THE PREVENTION OF NAUSEA AND VOMITING DURING CHEMOTHERAPY FOR CANCER
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M RIVA E PANZA MT DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S ROSSO R COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M DEPENNI R SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S MUTTINI MP CONTE PF SALVATI F NUNZIATI F SIGNORA M CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E TRINCA C LUPORINI G LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: F. Roila et al., DEXAMETHASONE, GRANISETRON, OR BOTH FOR THE PREVENTION OF NAUSEA AND VOMITING DURING CHEMOTHERAPY FOR CANCER, The New England journal of medicine, 332(1), 1995, pp. 1-5
RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE ANEMIA ASSOCIATED WITH MULTIPLE-MYELOMA OR NON-HODGKINS-LYMPHOMA - DOSE-FINDING AND IDENTIFICATION OF PREDICTORS OF RESPONSE
Authors: CAZZOLA M MESSINGER D BATTISTEL V BRON D CIMINO R ENLLERZIEGLER L ESSERS U GREIL R GROSSI A JAGER G LEMEVEL A NAJMAN A SILINGARDI V SPRIANO M VANHOOF A EHMER B
Citation: M. Cazzola et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE ANEMIA ASSOCIATED WITH MULTIPLE-MYELOMA OR NON-HODGKINS-LYMPHOMA - DOSE-FINDING AND IDENTIFICATION OF PREDICTORS OF RESPONSE, Blood, 86(12), 1995, pp. 4446-4453
HAIRY-CELL LEUKEMIA - A CLINICAL REVIEW BASED ON 725 CASES OF THE ITALIAN-COOPERATIVE-GROUP (ICGHCL)
Authors: FRASSOLDATI A LAMPARELLI T FEDERICO M ANNINO L CAPNIST G PAGNUCCO G DINI E RESEGOTTI L DAMASIO EE SILINGARDI V
Citation: A. Frassoldati et al., HAIRY-CELL LEUKEMIA - A CLINICAL REVIEW BASED ON 725 CASES OF THE ITALIAN-COOPERATIVE-GROUP (ICGHCL), Leukemia & lymphoma, 13(3-4), 1994, pp. 307-316
ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER
Authors: FAVALLI G ROILA F TONATO M DEANGELIS V BALLATORI E DELFAVERO A BASURTO C CORGNA E PALLADINO MA PICCIAFUOCO M CICCARESE G PATOIA L GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R SILINGARDI V MATERA G CELLERINO R DAZZI C MARANGOLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: G. Favalli et al., ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER, Supportive care in cancer, 2(3), 1994, pp. 167-170
LONG-TERM RESULTS OF ALPHA-INTERFERON AS INITIAL THERAPY AND SPLENECTOMY AS CONSOLIDATION THERAPY IN PATIENTS WITH HAIRY-CELL LEUKEMIA - FINAL REPORT FROM THE ITALIAN COOPERATIVE GROUP FOR HCL
Authors: FEDERICO M FRASSOLDATI A LAMPARELLI T FOA R BRUGIATELLI M ANNINO L BALDINI L CAPNIST G CHISESI T DICELLE PF INVERNIZZI R LAURIA F TRUINI M RESEGOTTI L SILINGARDI V DAMASIO EE
Citation: M. Federico et al., LONG-TERM RESULTS OF ALPHA-INTERFERON AS INITIAL THERAPY AND SPLENECTOMY AS CONSOLIDATION THERAPY IN PATIENTS WITH HAIRY-CELL LEUKEMIA - FINAL REPORT FROM THE ITALIAN COOPERATIVE GROUP FOR HCL, Annals of oncology, 5(8), 1994, pp. 725-731
Risultati: 1-25 | 26-27